Clinical Trials on Metastatic Castration Sensitive Prostate Cancer
Total 10739 results
-
British Columbia Cancer AgencyRecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)Canada
-
AstraZenecaCompletedProstate Cancer | Metastatic Castration-Resistant Prostate Cancer (mCRPC)United States
-
Advanced Accelerator ApplicationsNo longer availableMetastatic Castration-resistant Prostate Cancer (mCRPC)
-
AstraZenecaMerck Sharp & Dohme LLCRecruitingMetastatic Castration-resistant Prostate CancerGermany
-
AbbVieRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Israel
-
Bristol-Myers SquibbRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
AstraZenecaRecruitingMetastatic Castration-resistant Prostate CancerFrance
-
Oncternal Therapeutics, IncRecruitingMetastatic Castration-resistant Prostate CancerUnited States, United Kingdom
-
University of UtahExelixisRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
BAMF HealthTelix International Pty LtdRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
FutureChemRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Regeneron PharmaceuticalsRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Rahul AggarwalFortis Therapeutics, Inc.RecruitingProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Zenith EpigeneticsAstellas Pharma Inc; Newsoara Biopharma Co., Ltd.RecruitingMetastatic Castration-Resistant Prostate CancerUnited States, China
-
University of UtahRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Merck Sharp & Dohme LLCRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Austria, Canada, France, Germany, Ireland, Italy, Mexico, Netherlands, New Zealand, Poland, Russian Federation, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, Spain, Finland, Australia, Denmark
-
Laekna LimitedActive, not recruitingMetastatic Castration-resistant Prostate CancerUnited States, Korea, Republic of
-
Parker Institute for Cancer ImmunotherapyBristol-Myers Squibb; Cancer Research Institute, New York City; Celldex Therapeutics and other collaboratorsCompletedMetastatic Castration-resistant Prostate CancerUnited States
-
Brown UniversityBayer; The Miriam Hospital; Rhode Island Hospital; Clovis Oncology, Inc.Active, not recruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Williams Cancer FoundationSyncromune, Inc.Active, not recruitingPhase 1 Trial of SYNC-T - Immunotherapy for Advanced/Metastatic Castration-Resistant Prostate CancerMetastatic Castration-resistant Prostate CancerMexico
-
Astellas Pharma IncCompletedMetastatic Castration Resistant Prostate CancerIndia
-
AstraZenecaMerck Sharp & Dohme LLCActive, not recruitingMetastatic Castration-resistant Prostate CancerUnited States, Italy, Spain, Belgium, Canada, France, Korea, Republic of, United Kingdom, Brazil, Czechia, Turkey, Australia, Chile, Germany, Japan, Netherlands, Slovakia
-
Taiho Oncology, Inc.Active, not recruitingMetastatic Castration Resistant Prostate CancerFrance, United States, Spain, United Kingdom
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Terminated
-
Peking Union Medical College HospitalCompletedMetastatic Castration-resistant Prostate CancerChina
-
AmgenCompletedProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Austria, Singapore, Australia, Netherlands, France, Japan, Taiwan, Canada
-
ARTBIO Inc.Completed
-
Tceleron Therapeutics, Inc.TerminatedMetastatic Castration-resistant Prostate CancerUnited States
-
Peter MacCallum Cancer Centre, AustraliaCompletedMetastatic Castration Resistant Prostate CancerAustralia
-
National Cancer Institute (NCI)TerminatedCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
MediLink Therapeutics (Suzhou) Co., Ltd.RecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC)China
-
DendreonNot yet recruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)
-
Novartis PharmaceuticalsRecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)Spain, France
-
OncoC4, Inc.Prostate Cancer Clinical Trials ConsortiumRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
FutureChemActive, not recruitingMetastatic Castration-resistant Prostate Cancer, mCRPCKorea, Republic of
-
BayerActive, not recruitingBone Metastatic Castration-resistant Prostate CancerUnited Kingdom, France, Lithuania, Israel, Italy, Austria
-
Accutar Biotechnology IncTerminatedMetastatic Castration Resistant Prostate CancerUnited States
-
Peter MacCallum Cancer Centre, AustraliaSuspendedPidnarulex and Talazoparib in Patients With Metastatic Castration Resistant Prostate Cancer (REPAIR)Metastatic Castration Resistant Prostate Cancer (mCRPC)Australia
-
Istituto Scientifico Romagnolo per lo Studio e...TerminatedMetastatic Castration Resistant Prostate Cancer (mCRPC)Italy
-
Istituto Scientifico Romagnolo per lo Studio e...Active, not recruitingProstate Cancer | Metastatic Cancer | Castration-resistant Prostate Cancer | Circulating Tumor CellsItaly
-
Cancer Trials IrelandTerminatedMetastatic Cancer | Bone Metastases | Castration-resistant Prostate CancerIreland
-
Asana BioSciencesTerminatedProstate Cancer | Cancer of the Prostate | Neoplasms, Prostate | Prostatic Cancer | Neoplasms, Prostatic | Prostate Neoplasms, Castration-resistantUnited States
-
SL VAXiGENRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC)Korea, Republic of
-
Yantai LNC Biotechnology Singapore PTE. LTD.Not yet recruitingMetastatic Castration-resistant Prostate Cancer, mCRPC
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstatic Neoplasms | Metastatic Castration-resistant Prostate Cancer (mCRPC)Germany, United States, Puerto Rico, Israel, Australia, Korea, Republic of, Taiwan, China, Costa Rica, Guatemala, Spain, France, Hong Kong, Portugal, Romania
-
University of OklahomaDendreonRecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)United States
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMetastatic Castration-resistant Prostate Cancer | mCRPCAustralia
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)Australia
-
BayerActive, not recruitingNon-metastatic Castration-resistant Prostate CancerUnited States
-
BayerActive, not recruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)United States, United Kingdom, Finland